Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers.

Trial Profile

Phase 1 Randomized, Double-blind, Placebo-controlled Study of The Safety, Tolerability and Pharmacokinetics of Single, Ascending Oral Doses Of Bendavia in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2015

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Chronic heart failure; Myocardial infarction; Reperfusion injury
  • Focus Pharmacokinetics
  • Sponsors Stealth Peptides
  • Most Recent Events

    • 22 Jan 2013 Results have been reported in a Stealth Peptides media release.
    • 22 Jan 2013 Status changed from recruiting to completed based on information reported in a Stealth Peptides media release.
    • 20 Dec 2012 Status changed from planning to recruiting according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top